1. Home
  2. RDHL vs IVDA Comparison

RDHL vs IVDA Comparison

Compare RDHL & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • IVDA
  • Stock Information
  • Founded
  • RDHL 2009
  • IVDA 2003
  • Country
  • RDHL Israel
  • IVDA United States
  • Employees
  • RDHL N/A
  • IVDA N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • IVDA Computer Software: Prepackaged Software
  • Sector
  • RDHL Health Care
  • IVDA Technology
  • Exchange
  • RDHL Nasdaq
  • IVDA Nasdaq
  • Market Cap
  • RDHL 3.9M
  • IVDA 4.3M
  • IPO Year
  • RDHL N/A
  • IVDA N/A
  • Fundamental
  • Price
  • RDHL $1.34
  • IVDA $1.68
  • Analyst Decision
  • RDHL
  • IVDA
  • Analyst Count
  • RDHL 0
  • IVDA 0
  • Target Price
  • RDHL N/A
  • IVDA N/A
  • AVG Volume (30 Days)
  • RDHL 142.3K
  • IVDA 212.0K
  • Earning Date
  • RDHL 09-02-2025
  • IVDA 08-14-2025
  • Dividend Yield
  • RDHL N/A
  • IVDA N/A
  • EPS Growth
  • RDHL N/A
  • IVDA N/A
  • EPS
  • RDHL N/A
  • IVDA N/A
  • Revenue
  • RDHL $8,042,999.00
  • IVDA $7,142,302.00
  • Revenue This Year
  • RDHL $381.91
  • IVDA $340.48
  • Revenue Next Year
  • RDHL N/A
  • IVDA N/A
  • P/E Ratio
  • RDHL N/A
  • IVDA N/A
  • Revenue Growth
  • RDHL 23.17
  • IVDA 88.96
  • 52 Week Low
  • RDHL $1.06
  • IVDA $1.27
  • 52 Week High
  • RDHL $12.50
  • IVDA $8.05
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 42.30
  • IVDA 42.26
  • Support Level
  • RDHL $1.31
  • IVDA $1.42
  • Resistance Level
  • RDHL $1.48
  • IVDA $1.89
  • Average True Range (ATR)
  • RDHL 0.09
  • IVDA 0.14
  • MACD
  • RDHL 0.03
  • IVDA -0.02
  • Stochastic Oscillator
  • RDHL 65.48
  • IVDA 44.83

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

Share on Social Networks: